Literature DB >> 15795336

Predictors and consequences of negative physician attitudes toward HIV-infected injection drug users.

Lin Ding1, Bruce E Landon, Ira B Wilson, Mitchell D Wong, Martin F Shapiro, Paul D Cleary.   

Abstract

BACKGROUND: We evaluated physicians' training, experience, and practice characteristics and examined associations between their attitudes toward human immunodeficiency virus (HIV)-infected persons who are injection drug users (IDUs) and quality of care.
METHODS: Cross-sectional surveys were conducted among a probability sample of noninstitutionalized HIV-infected individuals in the United States and their main HIV care physicians. Physician and practice characteristics, training, HIV knowledge, experience, attitudes toward HIV-infected IDUs, stress levels, and satisfaction with practice were assessed. The main quality-of-care measures were patient exposure to highly active antiretroviral therapy, reported problems, satisfaction with care, unmet needs, and perceived access to care.
RESULTS: Nationally, 23.2% of HIV-infected patients had physicians with negative attitudes toward IDUs. Seeing more IDUs, having higher HIV treatment knowledge scores, and treating fewer patients per week were independently associated with more positive attitudes toward IDUs. Injection drug users who were cared for by physicians with negative attitudes had a significantly lower adjusted rate of exposure to highly active antiretroviral therapy by December 1996 (13.5%) than non-IDUs who were cared for by such physicians (36.1%) or IDUs who were cared for by physicians with positive attitudes (32.3%). Physician attitudes were not associated with other problems with care, satisfaction with care, unmet needs, or perceived access to care.
CONCLUSIONS: Negative attitudes may lead to less than optimal care for IDUs and other marginalized populations. Providing education or experience-based exercises or ensuring that clinicians have adequate time to deal with complex problems might result in better attitudes and higher quality of care.

Entities:  

Keywords:  Empirical Approach; Health Care and Public Health

Mesh:

Year:  2005        PMID: 15795336     DOI: 10.1001/archinte.165.6.618

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  54 in total

1.  Directly observed antiretroviral therapy in substance abusers receiving methadone maintenance therapy does not cause increased drug resistance.

Authors:  James C M Brust; Alain H Litwin; Karina M Berg; Xuan Li; Moonseong Heo; Julia H Arnsten
Journal:  AIDS Res Hum Retroviruses       Date:  2010-11-23       Impact factor: 2.205

2.  Case files from the Bellevue Hospital Center at New York University--lipoatrophy following long-term antiretroviral therapy.

Authors:  Demetre Daskalakis; Judith A Aberg
Journal:  MedGenMed       Date:  2005-10-11

3.  Do attitudes about unhealthy alcohol and other drug (AOD) use impact primary care professionals' readiness to implement AOD-related preventive care?

Authors:  Michaela B Amaral-Sabadini; Richard Saitz; Maria Lucia O Souza-Formigoni
Journal:  Drug Alcohol Rev       Date:  2010-11

4.  Directly administered antiretroviral therapy for HIV-infected drug users does not have an impact on antiretroviral resistance: results from a randomized controlled trial.

Authors:  Duncan Smith-Rohrberg Maru; Michael J Kozal; R Douglas Bruce; Sandra A Springer; Frederick L Altice
Journal:  J Acquir Immune Defic Syndr       Date:  2007-12-15       Impact factor: 3.731

5.  Barriers to antiretroviral treatment access for injecting drug users living with HIV in Chennai, South India.

Authors:  Venkatesan Chakrapani; Jaikumar Velayudham; Murali Shunmugam; Peter A Newman; Robert Dubrow
Journal:  AIDS Care       Date:  2013-11-28

6.  Negotiating substance use stigma: the role of cultural health capital in provider-patient interactions.

Authors:  Jamie Chang; Leslie Dubbin; Janet Shim
Journal:  Sociol Health Illn       Date:  2015-09-18

Review 7.  Challenges in managing HIV in people who use drugs.

Authors:  Adeeba Kamarulzaman; Frederick L Altice
Journal:  Curr Opin Infect Dis       Date:  2015-02       Impact factor: 4.915

8.  Opioid use trajectory groups and changes in a physical health biomarker among HIV-positive and uninfected patients receiving opioid agonist treatment.

Authors:  Kathleen A McGinnis; David A Fiellin; Melissa Skanderson; Yih-Ing Hser; Gregory M Lucas; Amy C Justice; Janet P Tate
Journal:  Drug Alcohol Depend       Date:  2019-09-04       Impact factor: 4.492

Review 9.  Neutropenia during HIV infection: adverse consequences and remedies.

Authors:  Xin Shi; Matthew D Sims; Michel M Hanna; Ming Xie; Peter G Gulick; Yong-Hui Zheng; Marc D Basson; Ping Zhang
Journal:  Int Rev Immunol       Date:  2014-03-21       Impact factor: 5.311

10.  A national physician survey on prescribing syringes as an HIV prevention measure.

Authors:  G E Macalino; D Dhawan Sachdev; J D Rich; C Becker; L J Tan; L Beletsky; S Burris
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.